Literature DB >> 14764061

Focal hyperplastic hepatocellular nodules in hepatic venous outflow obstruction: a clinicopathological study of four patients and 24 nodules.

C Ibarrola1, V M Castellano, F Colina.   

Abstract

AIMS: In hepatic venous outflow obstruction (Budd-Chiari syndrome), focal hepatocellular nodules are occasionally discovered showing variable morphology. These could be interpreted either as neoplastic (adenoma), regenerative (large regenerative nodule) or reactive to abnormal vasculature (focal nodular hyperplasia). The aim of this study was to investigate their histogenesis and to determine their morphological characteristics in order to provide diagnostic criteria.
MATERIAL AND METHODS: Twenty-four hepatocellular nodules were studied, which were found in three explanted livers and in one additional autopsied liver from four patients with Budd-Chiari syndrome. As controls, we employed three explanted livers without nodules from patients who also suffered from Budd-Chiari syndrome. We attempted to classify the nodules morphologically as either adenoma-like, large regenerative nodule or focal nodular hyperplasia-like, using criteria from the literature.
RESULTS: Out of the four cases, we observed two nodules in each of two livers, five in the third one and up to 15 in the remaining one. The size of the nodules ranged from 4 to 25 mm. Eleven nodules could be categorized as large regenerative nodules (two of them with a central scar), seven as focal nodular hyperplasia-like and six as adenoma-like. Some large regenerative nodules showed proliferated arteries with muscular hyperplasia similar to that seen in focal nodular hyperplasia. In the individual livers we could find nodules of various categories. Patchy or diffuse monoacinar regeneration was seen in most cases (six out of seven cases) in the macroscopically non-nodular liver parenchyma. In addition, thrombotic obstruction of portal vein branches was present in all except one of the nodular cases, but in none of the controls. Thus, it appears that portal venous obstructions are frequently, but not invariably associated with the development of nodules.
CONCLUSIONS: The hepatocellular nodules seen in livers from patients with Budd-Chiari syndrome share morphological characteristics with large regenerative nodules, focal nodular hyperplasia and hepatocellular adenomas. Their multiplicity, the existence of mixed lesions, the frequent hepatocellular regenerative background as well as the frequently associated portal venous obstructions suggest that these nodules are regenerative in nature and conditioned by an uneven blood perfusion throughout the liver. In their differential diagnosis, the clinicopathological context in which they occur is of paramount importance and should allow recognition that those resembling adenomas may not be true neoplasms.

Entities:  

Mesh:

Year:  2004        PMID: 14764061     DOI: 10.1111/j.1365-2559.2004.01795.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  14 in total

Review 1.  [Nodular lesions of liver parenchyma caused by pathological vascularisation/perfusion].

Authors:  H-P Fischer; H Zhou
Journal:  Pathologe       Date:  2006-07       Impact factor: 1.011

2.  Hepatic pathology after Fontan palliation: spectrum of imaging findings.

Authors:  Daniel B Wallihan; Daniel J Podberesky
Journal:  Pediatr Radiol       Date:  2012-10-06

Review 3.  Hepatocellular nodules in vascular liver diseases.

Authors:  Christine Sempoux; Charles Balabaud; Valérie Paradis; Paulette Bioulac-Sage
Journal:  Virchows Arch       Date:  2018-05-26       Impact factor: 4.064

4.  Rapid development of a hepatocellular carcinoma in isolated thrombosis of hepatic veins (classic Budd-Chiari syndrome): case report and review of literature.

Authors:  Jens Walldorf; Andrea Tannapfel; Hans Jürgen Holzhausen; Christian Wittekind; Thomas Seufferlein; Utz Settmacher; Wolfgang E Fleig; Matthias M Dollinger
Journal:  BMJ Case Rep       Date:  2009-11-29

5.  Quantitative gene expression in Budd-Chiari syndrome: a molecular approach to the pathogenesis of the disease.

Authors:  V Paradis; I Bièche; D Dargère; D Cazals-Hatem; I Laurendeau; V Saada; J Belghiti; A Bezeaud; M Vidaud; P Bedossa; D-C Valla
Journal:  Gut       Date:  2005-09-14       Impact factor: 23.059

Review 6.  Radiological and histopathological manifestations of hepatocellular nodular lesions concomitant with various congenital and acquired hepatic hemodynamic abnormalities.

Authors:  Satoshi Kobayashi; Osamu Matsui; Toshifumi Gabata; Junichiro Sanada; Wataru Koda; Tetsuya Minami; Yasuji Ryu
Journal:  Jpn J Radiol       Date:  2009-03-12       Impact factor: 2.374

7.  Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL).

Authors:  Akash Shukla; Ananta Shreshtha; Amar Mukund; Chhagan Bihari; C E Eapen; Guohong Han; Hemant Deshmukh; Ian Homer Y Cua; Cosmas Rinaldi Adithya Lesmana; Mamun Al Meshtab; Masayoshi Kage; Roongruedee Chaiteeraki; Sombat Treeprasertsuk; Suprabhat Giri; Sundeep Punamiya; Valerie Paradis; Xingshun Qi; Yasuhiko Sugawara; Zaigham Abbas; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2021-07-08       Impact factor: 6.047

Review 8.  Hepatocellular adenomas: recent updates.

Authors:  Haeryoung Kim; Young Nyun Park
Journal:  J Pathol Transl Med       Date:  2021-04-07

Review 9.  That liver lesion on MDCT in the oncology patient: is it important?

Authors:  Richard M Gore; Kiran H Thakrar; Daniel R Wenzke; Geraldine M Newmark; Uday K Mehta; Jonathan W Berlin
Journal:  Cancer Imaging       Date:  2012-09-28       Impact factor: 3.909

10.  Budd-Chiari syndrome with multiple large regenerative nodules.

Authors:  Haeryoung Kim; Ji Hae Nahm; Young Nyun Park
Journal:  Clin Mol Hepatol       Date:  2015-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.